Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CDK4 | P11802 | 1/20 | 0.31 |
| ▸ | CCND1 | P24385 | 1/20 | 0.31 |
| ▸ | MAP3K9 | P80192 | 1/20 | 0.31 |
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19320176 | 0.89 | KDM4E (0.41) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL17548802 | 0.85 | MAP3K9 (0.38) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL19320172 | 0.84 | MAP3K9 (0.36) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL19320181 | 0.83 | MEN1 (0.39) | KDM4EMEN1MAPTRAB9AKMT2A | |
| SCHEMBL19325075 | 0.82 | MEN1 (0.40) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL19320159 | 0.82 | OPRM1 (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL19320168 | 0.81 | HTR2B (0.33) | MEN1MAPTRAB9AKMT2ACDK4 | |
| SCHEMBL18132849 | 0.80 | MEN1 (0.41) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL19546422 | 0.79 | MAP3K9 (0.40) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL18132861 | 0.79 | MEN1 (0.40) | KDM4EATML3MBTL1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20190103561-A1 | Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same | DUK SAN NEOLUX CO., LTD (KR) | 2019-04-04 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | ORAI2, VDAC2, PIEZO1 | KDM4E 594/4885ATM 2903/4885L3MBTL1 783/4885 |
| US-20190103561-A1 | Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same | ORAI2, VDAC2, PIEZO1 | KDM4E 594/4885ATM 2903/4885L3MBTL1 783/4885 |
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | ORAI2, VDAC2, PIEZO1 | KDM4E 594/4885ATM 2903/4885L3MBTL1 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.